Patents Assigned to M Bio Technology Inc.
  • Glyceroglycolipid antigen of
    Patent number: 8367076
    Abstract: The present invention provides a novel glyceroglycolipid produced by Mycoplasma pneumoniae. The glyceroglycolipid can be used as a diagnostic marker for a disease caused by Mycoplasma pneumoniae.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: February 5, 2013
    Assignee: M Bio Technology Inc.
    Inventors: Kazuhiro Matsuda, Yuko Shingu